Results 1 to 10 of about 3,959 (161)

Reply letter to “safety of SARS-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance” [PDF]

open access: yesHuman Vaccines and Immunotherapeutics, 2021
In the letter, Urro et al. performed a search on the sucrose, fructose and sorbitol content in the approved Sars-Cov-2 vaccines and they concluded that these vaccines can be safely administered in adults affected by Hereditary fructose intolerance.
Rosaura Leis   +2 more
exaly   +5 more sources

Transferrin Isoforms, Old but New Biomarkers in Hereditary Fructose Intolerance [PDF]

open access: yesJournal of Clinical Medicine, 2021
Hereditary Fructose Intolerance (HFI) is an autosomal recessive inborn error of metabolism characterised by the deficiency of the hepatic enzyme aldolase B. Its treatment consists in adopting a fructose-, sucrose-, and sorbitol (FSS)-restrictive diet for
Javier Adolfo De Las Heras Montero   +2 more
exaly   +6 more sources

Letter to the editor concerning the article ‘Safety of vaccines administration in hereditary fructose intolerance’ [PDF]

open access: yesHuman Vaccines and Immunotherapeutics, 2021
The most important approach for the management of hereditary fructose intolerance is a strict avoidance of fructose, sucrose and sorbitol from the diet and medications.
Rosaura Leis   +2 more
exaly   +5 more sources

Hereditary Fructose Intolerance Diagnosed in Adulthood. [PDF]

open access: yesGut Liver, 2021
Hereditary fructose intolerance (HFI) is an autosomal recessive disorder caused by a mutation in the aldolase B gene. HFI patients exhibit nausea, vomiting, abdominal pain, hypoglycemia, and elevated liver enzymes after dietary fructose exposure. Chronic exposure might lead to failure to thrive, liver failure, renal failure, and, eventually, death. HFI
Kim MS   +5 more
europepmc   +8 more sources

Endogenous Fructose Production and Metabolism Drive Metabolic Dysregulation and Liver Disease in Mice with Hereditary Fructose Intolerance. [PDF]

open access: yesNutrients, 2023
Excessive intake of sugar, and particularly fructose, is closely associated with the development and progression of metabolic syndrome in humans and animal models. However, genetic disorders in fructose metabolism have very different consequences.
Andres-Hernando A   +8 more
europepmc   +4 more sources

Development of tools to facilitate the diagnosis of hereditary fructose intolerance. [PDF]

open access: yesJIMD Rep, 2023
Although hereditary fructose intolerance (HFI) is an inborn error of fructose metabolism that classically presents at infancy, the diagnosis is often missed or delayed. In this study, we aimed to develop tools to facilitate the diagnosis of HFI.
Panis B   +5 more
europepmc   +4 more sources

Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance [PDF]

open access: yesHuman Vaccines and Immunotherapeutics, 2021
We have read with great interest the Letter to the editor written by Saborido-Fiaño et al. in an issue of Human Vaccines & Immunotherapeutics concerning the article “Safety of vaccines administration in hereditary fructose intolerance”, recently ...
Silvana Anna Maria Urru, Evelina Maines
exaly   +3 more sources

Safety and efficacy of pharmacological inhibition of ketohexokinase in hereditary fructose intolerance. [PDF]

open access: yesJ Clin Invest
To the editor: Hereditary fructose intolerance (HFI) is an inborn error of fructose metabolism caused by a defect in aldolase B (ALDOB). Ingestion of fructose results in rapid accumulation of fructose 1-phosphate (Fru-1P) and depletion of inorganic ...
Koene EJ   +12 more
europepmc   +2 more sources

Hereditary fructose intolerance: A comprehensive review. [PDF]

open access: yesWorld J Clin Pediatr, 2022
Hereditary fructose intolerance (HFI) is a rare autosomal recessive inherited disorder that occurs due to the mutation of enzyme aldolase B located on chromosome 9q22.3.
Singh SK, Sarma MS.
europepmc   +2 more sources

Combined PMM2-CDG and hereditary fructose intolerance in a patient with mild clinical presentation. [PDF]

open access: yesMol Genet Metab, 2023
We report a patient with an extremely rare, combined diagnosis of PMM2-CDG and hereditary fructose intolerance (HFI). By comparing with other patients, under-galactosylation was identified as a feature of HFI.
Hong X   +6 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy